0001169245-21-000089.txt : 20210903 0001169245-21-000089.hdr.sgml : 20210903 20210903164336 ACCESSION NUMBER: 0001169245-21-000089 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210712 FILED AS OF DATE: 20210903 DATE AS OF CHANGE: 20210903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arnold Susan Elizabeth CENTRAL INDEX KEY: 0001755746 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38697 FILM NUMBER: 211237095 MAIL ADDRESS: STREET 1: C/O PHASEBIO PHARMACEUTICALS, INC. STREET 2: 1 GREAT VALLEY DRIVE, SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 4/A 1 wf-form4a_163070178763813.xml FORM 4/A X0306 4/A 2021-07-12 2021-07-14 0 0001169245 PhaseBio Pharmaceuticals Inc PHAS 0001755746 Arnold Susan Elizabeth C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY PARKWAY, SUITE 30 MALVERN PA 19355 0 1 0 0 VP, Preclinical and Chem Common Stock 2021-07-12 4 M 0 4519 1.74 A 27760 D Employee Stock Option (right to buy) 1.74 2021-07-12 4 M 0 4519 0 D 2015-07-12 2021-07-12 Common Stock 4519.0 0 D Amended to correct the transaction code for common stock acquired through stock options exercised in a transaction on July 12, 2021. Amended to add a transaction for the exercise of stock options on July 12, 2021. All shares underlying this option have vested. /s/ John P. Sharp, Attorney-in-fact 2021-09-03